Larvol Delta - Allakos-Announces-Topline-Results-from-its-Phase-1-Trial-of-AK006-in-Patients-with-Chronic-Spontaneous-Urticaria-and-Announces-Restructuring

AK006 - Allakos

https://www.globenewswire.com/news-release/2025/01/27/3015460/0/en/Allakos-Announces-Topline-Results-from-its-Phase-1-Trial-of-AK006-in-Patients-with-Chronic-Spontaneous-Urticaria-and-Announces-Restructuring.html

Jan 27, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next